82073429, 82273510, 82430101), Innovation Program of Shanghai Municipal Education Commission (No.2019-01-07-00-07-E00046), Clinical Research Plan of SHDC (No.2020CR1014B, 22022302, 2020CR6022), Shanghai Science and Technology Development Funds (24YF2738100)
Dispensador automtico
Most importantly, injectable formats are prescribed and administered under medical supervision, which helps ensure proper dosing, safety, and program suitability for each individual
They do not contain semaglutide, liraglutide, or any pharmaceutical compound
Patients using transdermal patches (with or without GLP-1 drugs) may experience reactions to the transdermal patch
PMID 9565586